A carregar...

Metabolism remodeling in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of death of patients with malignant cancers by 2030. Current options of PDAC treatment are limited and the five-year survival rate is less than 8%, leading to an urgent need to explore innovatively therapeutic st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Stress
Main Authors: Li, Jin-Tao, Wang, Yi-Ping, Yin, Miao, Lei, Qun-Ying
Formato: Artigo
Idioma:Inglês
Publicado em: Shared Science Publishers OG 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6883744/
https://ncbi.nlm.nih.gov/pubmed/31832601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15698/cst2019.12.205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!